サンプル依頼リスト カート
  • English
  • Korean
表紙：舌下アレルギー免疫療法の市場調査：花粉症向けSLITソリューションが市場収益の50%以上を占める
市場調査レポート
商品コード
1308087

舌下アレルギー免疫療法の市場調査：花粉症向けSLITソリューションが市場収益の50%以上を占める

Market Study on Sublingual Allergy Immunotherapy: Over 50% Market Revenue Comes from SLIT Solutions for Pollen Allergies
出版日: | 発行: Persistence Market Research | ページ情報: 英文 258 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
舌下アレルギー免疫療法の市場調査：花粉症向けSLITソリューションが市場収益の50%以上を占める
出版日: 2023年06月12日
発行: Persistence Market Research
ページ情報: 英文 258 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

舌下アレルギー免疫療法市場：調査範囲

Persistence Market Research社の最新レポート「世界の舌下アレルギー免疫療法市場」は、市場機会と現在の市場情勢を評価し、市場に影響を与える対応セクションに関する詳細な分析と最新情報を提供しています。市場の促進要因、市場抑制要因、動向、機会を含む現在の市場力学に関する詳細な洞察を提供しています。市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占的な情報を提示することです。

市場の成功成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Researchの調査で網羅的に説明されています。この調査により、読者は舌下アレルギー免疫療法薬の需要と調査期間中の定量的な研究開発機会を知ることができます。

この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーを含むランドスケープにおける株主にとって有益であり、舌下アレルギー免疫療法市場で繁栄するための適切な事業戦略を策定するのに役立ちます。舌下アレルギー免疫療法市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。

市場統計、ならびに舌下アレルギー免疫療法市場のビジネスシナリオに影響を与えるマクロ経済変数およびマクロ経済変数に関連する情報も本調査に含まれています。市場の潜在的開拓によっては、実質的な洞察も本レポートに記載されています。さらに、本レポートで提出されたデータにより、業界のマイナー企業や新規参入企業は、市場での牽引力を達成するために適切な企業選択を行う際に役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場カバレッジ/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション/開発動向

第4章 付加価値に関する洞察

  • 地域別の主要な適応症の疫学
  • 製品の採用/使用状況の分析
  • パイプラインの評価
  • 規制シナリオ
  • 償還の情勢
  • PESTLE分析
  • ポーター分析
  • 最新の業界取引/M&A

第5章 世界の舌下アレルギー免疫療法市場の分析と2023～2033年の予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長傾向分析

第6章 世界の舌下アレルギー免疫療法市場- 価格分析

  • 医薬品ごとの地域価格分析
  • 世界平均価格分析ベンチマーク
  • 価格の仮定

第7章 世界の舌下アレルギー免疫療法市場の需要、2015～2022年の分析と2023～2033年の予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長傾向分析
    • 絶対的な金額の機会分析

第8章 市場の背景

  • マクロ経済的要因
  • 予測要因- 関連性と影響
  • 市場力学

第9章 世界の舌下アレルギー免疫療法市場の分析と予測：医薬品別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場予測
    • ODACTRA
    • GRASTEK
    • RAGWITEK
    • ORALAIR
    • ACTAIR
    • その他
  • 医薬品別市場魅力度分析

第10章 世界の舌下アレルギー免疫療法市場の分析と予測：適応症別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場予測
    • アレルギー性鼻炎
    • アレルギー性喘息
    • 食物アレルギー
    • アトピー性皮膚炎
    • その他
  • 適応症別の市場魅力分析

第11章 世界の舌下アレルギー免疫療法市場の分析と予測：アレルゲンタイプ別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場予測
    • 花粉
    • ハウスダストダニ（HDM）
    • 型
    • 動物の鱗屑
    • 蜂の毒
    • ゴキブリ・昆虫
    • その他
  • アレルゲンタイプ別市場魅力分析

第12章 世界の舌下アレルギー免疫療法市場の分析と予測：流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場予測
    • 法人向け販売
      • 政府病院
      • 準政府病院
      • 私立病院
    • 小売販売
      • 小売薬局
      • ドラッグストア
      • オンライン薬局
  • 流通チャネル別の市場魅力分析

第13章 世界市場の分析と予測：地域別

  • イントロダクション
  • 過去の市場分析
  • 現在および将来の市場予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（MEA）
  • 地域別市場魅力分析

第14章 北米の市場の分析と予測

第15章 ラテンアメリカの市場の分析と予測

第16章 欧州の市場の分析と予測

第17章 東アジアの市場の分析と予測

第18章 南アジアの市場の分析と予測

第19章 オセアニアの市場の分析と予測

第20章 中東およびアフリカ（MEA）の市場の分析と予測

第21章 市場構造分析

  • 企業階層別の市場分析
  • 主要企業の市場シェア分析
  • 市場の集中
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 主要企業別ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • ALK Abello
    • Stallergenes Greer
    • Allergy Therapeutics
    • Aimmune Therapeutics
    • Biomay AG
    • HAL Allergy group
    • DBV Technologies
    • Merck KGaA
    • WOLWpharma

第23章 使用される仮定と略語

第24章 調査手法

図表

List of Tables

  • Table 01: Global Sublingual Allergy Immunotherapy Market Volume (Mn Units) Analysis and Opportunity Assessment 2015-2023, By Region

Table 02A: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug

Table 02B: Global Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug

  • Table 03: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 04: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 05: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 06: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 07: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 08: North America Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 09: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 10: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 11: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 12: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 13: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 14: Latin America Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 15: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 16: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 17: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 18: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 19: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 20: Europe Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 21: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 22: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 23: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 24: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 25: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 26: South Asia Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 27: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 28: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 29: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 30: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 31: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 32: East Asia Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 33: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 34: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 35: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 36: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 37: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 38: Oceania Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 39: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 40: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 41: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
  • Table 42: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 43: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
  • Table 44: Middle East & Africa Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
  • Table 45: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
  • Table 46: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
  • Table 47: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel

List of Figures

  • Figure 01: Global Sublingual Allergy Immunotherapy Market Volume (Units), 2015 - 2022
  • Figure 02: Global Sublingual Allergy Immunotherapy Market Volume (Units) & Y-o-Y Growth (%) Analysis,
  • Figure 03: SLIT drugs, Pricing Analysis per unit (US$), in 2022
  • Figure 04: SLIT drugs, Pricing Forecast per unit (US$), in 2033
  • Figure 05: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 06: Global Sublingual Allergy Immunotherapy Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 07: Global Sublingual Allergy Immunotherapy Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 08: Global Sublingual Allergy Immunotherapy Market Value Share (%) Analysis 2022 and 2033, by Drug
  • Figure 09: Global Sublingual Allergy Immunotherapy Market Y-o-Y Growth (%) Analysis 2022-2033, by Drug
  • Figure 10: Global Sublingual Allergy Immunotherapy Market Attractiveness Analysis 2023-2033, by Drug
  • Figure 11: Global Sublingual Allergy Immunotherapy Market Value Share (%) Analysis 2022 and 2033, by Indication
  • Figure 12: Global Sublingual Allergy Immunotherapy Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication
  • Figure 13: Global Sublingual Allergy Immunotherapy Market Attractiveness Analysis 2023-2033, by Indication
  • Figure 14: Global Sublingual Allergy Immunotherapy Market Value Share (%) Analysis 2022 and 2033, by Allergen
  • Figure 15: Global Sublingual Allergy Immunotherapy Market Y-o-Y Growth (%) Analysis 2022-2033, by Allergen
  • Figure 16: Global Sublingual Allergy Immunotherapy Market Attractiveness Analysis 2023-2033, by Allergen
  • Figure 17: Global Sublingual Allergy Immunotherapy Market Value Share (%) Analysis 2022 and 2033, by Distribution Channel
  • Figure 18: Global Sublingual Allergy Immunotherapy Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
  • Figure 19: Global Sublingual Allergy Immunotherapy Market Attractiveness Analysis 2023-2033, by Distribution Channel
  • Figure 20: Global Sublingual Allergy Immunotherapy Market Value Share (%) Analysis 2022 and 2033, by Region
  • Figure 21: Global Sublingual Allergy Immunotherapy Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 22: Global Sublingual Allergy Immunotherapy Market Attractiveness Analysis 2023-2033, by Region
  • Figure 23: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 24: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 25: North America Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 26: North America Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 27: North America Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 28: North America Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 29: North America Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 30: North America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 31: North America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 32: North America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 33: North America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 34: North America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 35: U.S. Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 36: Global Vs. U.S. Growth Comparison, 2022 - 2033
  • Figure 37: U.S. Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 38: U.S. Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 39: U.S. Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 40: U.S. Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 41: Canada Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 42: Global Vs. Canada. Growth Comparison, 2022 - 2033
  • Figure 43: Canada Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 44: Canada Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 45: Canada Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 46: Canada Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 47: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 48: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 49: Latin America Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 50: Latin America Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 51: Latin America Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 52: Latin America Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 53: Latin America Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 54: Latin America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 55: Latin America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 56: Latin America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 57: Latin America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 58: Latin America Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 59: Mexico Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 60: Global Vs Mexico Growth Comparison, 2022 - 2033
  • Figure 61: Mexico Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 62: Mexico Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 63: Mexico Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 64: Mexico Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 65: Brazil Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 66: Global Vs. Brazil. Growth Comparison, 2022 - 2033
  • Figure 67: Brazil Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 68: Brazil Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 69: Brazil Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 70: Brazil Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 71: Argentina Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs Argentina Growth Comparison, 2022 - 2033
  • Figure 73: Argentina Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 74: Argentina Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 75: Argentina Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 76: Argentina Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 77: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 78: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 79: Europe Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 80: Europe Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 81: Europe Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 82: Europe Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 83: Europe Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 84: Europe Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 85: Europe Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 86: Europe Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 87: Europe Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 88: Europe Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 89: UK Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 90: Global Vs. UK Growth Comparison, 2022 - 2033
  • Figure 91: UK Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 92: UK Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 93: UK Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 94: UK Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 95: Germany Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 96: Global Vs. Germany Growth Comparison, 2022 - 2033
  • Figure 97: Germany Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 98: Germany Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 99: Germany Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 100: Germany Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 101: Italy Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 102: Global Vs. Italy Growth Comparison, 2022 - 2033
  • Figure 103: Italy Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 104: Italy Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 105: Italy Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 106: Italy Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 107: France Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 108: Global Vs France Growth Comparison, 2022 - 2033
  • Figure 109: France Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 110: France Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 111: France Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 112: France Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 113: Spain Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 114: Global Vs Spain Growth Comparison, 2022 - 2033
  • Figure 115: Spain Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 116: Spain Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 117: Spain Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 118: Spain Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 119: Russia Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 120: Global Vs Russia Growth Comparison, 2022 - 2033
  • Figure 121: Russia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 122: Russia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 123: Russia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 124: Russia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 125: BENELUX Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 126: Global Vs BENELUX Growth Comparison, 2022 - 2033
  • Figure 127: BENELUX Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 128: BENELUX Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 129: BENELUX Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 130: BENELUX Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 131: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 132: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 133: East Asia Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 134: East Asia Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 135: East Asia Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 136: East Asia Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 137: East Asia Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 138: East Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 139: East Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 140: East Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 141: East Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 142: East Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 143: China Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 144: Global Vs. China Growth Comparison, 2022 - 2033
  • Figure 145: China Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 146: China Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 147: China Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 148: China Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 149: Japan Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 150: Global Vs. Japan Growth Comparison, 2022 - 2033
  • Figure 151: Japan Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 152: Japan Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 153: Japan Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 154: Japan Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 155: South Korea Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 156: Global Vs South Korea Growth Comparison, 2022 - 2033
  • Figure 157: South Korea Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 158: South Korea Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 159: South Korea Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 160: South Korea Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 161: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 162: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 163: South Asia Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 164: South Asia Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 165: South Asia Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 166: South Asia Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 167: South Asia Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 168: South Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 169: South Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 170: South Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 171: South Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 172: South Asia Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 173: India Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 174: Global Vs. India Growth Comparison, 2022 - 2033
  • Figure 175: India Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 176: India Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 177: India Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 178: India Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 179: Indonesia Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 180: Global Vs. Indonesia Growth Comparison, 2022 - 2033
  • Figure 181: Indonesia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 182: Indonesia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 183: Indonesia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 184: Indonesia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 185: Malaysia Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 186: Global Vs. Malaysia Growth Comparison, 2022 - 2033
  • Figure 187: Malaysia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 188: Malaysia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 189: Malaysia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 190: Malaysia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 191: Thailand Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 192: Global Vs. Thailand Growth Comparison, 2022 - 2033
  • Figure 193: Thailand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 194: Thailand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 195: Thailand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 196: Thailand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 197: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 198: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 199: Oceania Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 200: Oceania Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 201: Oceania Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 202: Oceania Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 203: Oceania Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 204: Oceania Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 205: Oceania Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 206: Oceania Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 207: Oceania Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 208: Oceania Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 209: Australia Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 210: Global Vs. Australia Growth Comparison, 2022 - 2033
  • Figure 211: Australia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 212: Australia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 213: Australia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 214: Australia Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 215: New Zealand Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 216: Global Vs New Zealand Growth Comparison, 2022 - 2033
  • Figure 217: New Zealand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 218: New Zealand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 219: New Zealand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 220: New Zealand Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 221: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis, 2015 - 2022
  • Figure 222: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2022-2033
  • Figure 223: Middle East & Africa Sublingual Allergy Immunotherapy Market Value Share, by Drug (2022 A)
  • Figure 224: Middle East & Africa Sublingual Allergy Immunotherapy Market Value Share, by Indication (2022 A)
  • Figure 225: Middle East & Africa Sublingual Allergy Immunotherapy Market Value Share, by Allergen (2022 A)
  • Figure 226: Middle East & Africa Sublingual Allergy Immunotherapy Market Value Share, by Distribution Channel (2022 A)
  • Figure 227: Middle East & Africa Sublingual Allergy Immunotherapy Market Value Share, by Country (2022 A)
  • Figure 228: Middle East & Africa Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 229: Middle East & Africa Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2023-2033
  • Figure 230: Middle East & Africa Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2023-2033
  • Figure 231: Middle East & Africa Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 232: Middle East & Africa Sublingual Allergy Immunotherapy Market Attractiveness Analysis by Country, 2023-2033
  • Figure 233: GCC Countries Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 234: Global Vs GCC Countries Growth Comparison, 2022 - 2033
  • Figure 235: GCC Countries Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 236: GCC Countries Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 237: GCC Countries Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 238: GCC Countries Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 239: Turkiye Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 240: Global Vs. Turkiye Growth Comparison, 2022 - 2033
  • Figure 241: Turkiye Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 242: Turkiye Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 243: Turkiye Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 244: Turkiye Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 245: South Africa Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 246: Global Vs. South Africa Growth Comparison, 2022 - 2033
  • Figure 247: South Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 248: South Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 249: South Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 250: South Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 251: North Africa Sublingual Allergy Immunotherapy Market Value Proportion Analysis, 2022
  • Figure 252: Global Vs North Africa Growth Comparison, 2022 - 2033
  • Figure 253: North Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 254: North Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Indication, 2022 & 2033
  • Figure 255: North Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Allergen, 2022 & 2033
  • Figure 256: North Africa Sublingual Allergy Immunotherapy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
目次
Product Code: PMRREP14968

Sublingual Allergy Immunotherapy Market: Report Scope

The latest publication by Persistence Market Research on the global sublingual allergy immunotherapy market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for sublingual allergy immunotherapy drugs and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the sublingual allergy immunotherapy market. Shareholders in the sublingual allergy immunotherapy market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the sublingual allergy immunotherapy market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the sublingual allergy immunotherapy market offers information divided into five important segments - drug, indication, allergen, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Attribute Details:

Drug

  • Odactra
  • Grastek
  • Ragwitek
  • Oralair
  • Actair
  • Others

Indication

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen

  • Pollen
  • Grass Pollen
  • Weed Pollen
  • Tree Pollen
  • House Dust Mites
  • Mould
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

Distribution Channel

  • Institutional Sales
  • Government Hospitals
  • Semi-Government Hospitals
  • Private Hospitals
  • Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in Report:

  • Which regions will continue to remain the most profitable markets for sublingual allergy immunotherapy over the coming years?
  • How will changing trends influence the market?
  • How has the COVID-19 crisis influenced market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will influence the market?
  • How can companies in the sublingual allergy immunotherapy market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the sublingual allergy immunotherapy market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the sublingual allergy immunotherapy market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Epidemiology of Key Indication, By Region
  • 4.2. Product Adoption/Usage Analysis
  • 4.3. Pipeline Assessment
  • 4.4. Regulatory Scenario
  • 4.5. Reimbursement Landscape
  • 4.6. PESTLE Analysis
  • 4.7. PORTER Analysis
  • 4.8. Latest Industry Deals/M&A

5. Global Market Demand Analysis 2015-2022 and Forecast, 2023-2033

  • 5.1. Historical Market Volume (Units) Analysis, 2015-2022
  • 5.2. Current and Future Market Volume (Units) Projections, 2023-2033
    • 5.2.1. Y-o-Y Growth Trend Analysis

6. Global Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis By Drug
  • 6.2. Global Average Pricing Analysis Benchmark
  • 6.3. Pricing Assumptions

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Global Healthcare GDP Growth Overview
    • 8.1.3. Global Geriatric Population
    • 8.1.4. Global R&D Funding and Infrastructure Investment
    • 8.1.5. Global Allergy Immunotherapy Market Overview
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Rising Prevalence Asthma.
    • 8.2.2. Increasing Awareness for food allergy.
    • 8.2.3. Increasing Healthcare Spending.
    • 8.2.4. Rising focus on strengthening of immune system
    • 8.2.5. Rising geriatric population
    • 8.2.6. Rise In industrialization in regions
    • 8.2.7. Rise of population due to industrial waste
    • 8.2.8. Research and development in immunotherapeutic drugs.
  • 8.3. Market Dynamics
    • 8.3.1. Drivers
    • 8.3.2. Restraints
    • 8.3.3. Opportunity Analysis

9. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Drug

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) and Trend Analysis and Forecast By Drug, 2023-2033
    • 9.3.1. ODACTRA
    • 9.3.2. GRASTEK
    • 9.3.3. RAGWITEK
    • 9.3.4. ORALAIR
    • 9.3.5. ACTAIR
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis By Drug

10. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
    • 10.3.1. Allergic Rhinitis
    • 10.3.2. Allergic Asthma
    • 10.3.3. Food Allergy
    • 10.3.4. Atopic Dermatitis
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Indication

11. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Allergan Type

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Allergan Type, 2015-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergan Type, 2023-2033
    • 11.3.1. Pollens
    • 11.3.2. House Dust Mites (HDM)
    • 11.3.3. Mould
    • 11.3.4. Animal Dander
    • 11.3.5. Bee Venom
    • 11.3.6. Cockroaches/Insects
    • 11.3.7. Others
  • 11.4. Market Attractiveness Analysis By Allergan Type

12. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2015-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
    • 12.3.1. Institutional Sales
      • 12.3.1.1. Gov. Hospitals
      • 12.3.1.2. Semi-Gov. Hospitals
      • 12.3.1.3. Private Hospitals
    • 12.3.2. Retail Sales
      • 12.3.2.1. Retail Pharmacy
      • 12.3.2.2. Drug Stores
      • 12.3.2.3. Online Pharmacy
  • 12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2015-2022
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Drug
    • 14.3.3. By Indication
    • 14.3.4. By Allergan Type
    • 14.3.5. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug
    • 14.4.3. By Indication
    • 14.4.4. By Allergan Type
    • 14.4.5. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market Analysis
      • 14.8.1.1. .Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Drug
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Allergan Type
        • 14.8.1.2.4. By Distribution Channel
    • 14.8.2. Canada Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Drug
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Allergan Type
        • 14.8.2.2.4. By Distribution Channel

15. Latin America Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Drug
    • 15.3.3. By Indication
    • 15.3.4. By Allergan Type
    • 15.3.5. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug
    • 15.4.3. By Indication
    • 15.4.4. By Allergan Type
    • 15.4.5. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Drug
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Allergan Type
        • 15.8.1.2.4. By Distribution Channel
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Drug
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Allergan Type
        • 15.8.2.2.4. By Distribution Channel
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Drug
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Allergan Type
        • 15.8.3.2.4. By Distribution Channel

16. Europe Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. U.K.
      • 16.3.1.3. France
      • 16.3.1.4. Spain
      • 16.3.1.5. Benelux
      • 16.3.1.6. Russia
      • 16.3.1.7. Italy
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Drug
    • 16.3.3. By Indication
    • 16.3.4. By Allergan Type
    • 16.3.5. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug
    • 16.4.3. By Indication
    • 16.4.4. By Allergan Type
    • 16.4.5. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Drug
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Allergan Type
        • 16.8.1.2.4. By Distribution Channel
    • 16.8.2. U.K. Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Drug
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Allergan Type
        • 16.8.2.2.4. By Distribution Channel
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Drug
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Allergan Type
        • 16.8.3.2.4. By Distribution Channel
    • 16.8.4. Spain Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Drug
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By Allergan Type
        • 16.8.4.2.4. By Distribution Channel
    • 16.8.5. BENELUX Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Drug
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By Allergan Type
        • 16.8.5.2.4. By Distribution Channel
    • 16.8.6. Russia Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Drug
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By Allergan Type
        • 16.8.6.2.4. By Distribution Channel
    • 16.8.7. Italy Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Drug
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By Allergan Type
        • 16.8.7.2.4. By Distribution Channel

17. East Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Drug
    • 17.3.3. By Indication
    • 17.3.4. By Allergan Type
    • 17.3.5. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug
    • 17.4.3. By Indication
    • 17.4.4. By Allergan Type
    • 17.4.5. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Drug
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Allergan Type
        • 17.8.1.2.4. By Distribution Channel
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Drug
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Allergan Type
        • 17.8.2.2.4. By Distribution Channel
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Drug
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By Allergan Type
        • 17.8.3.2.4. By Distribution Channel

18. South Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Drug
    • 18.3.3. By Indication
    • 18.3.4. By Allergan Type
    • 18.3.5. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug
    • 18.4.3. By Indication
    • 18.4.4. By Allergan Type
    • 18.4.5. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Drug
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Allergan Type
        • 18.8.1.2.4. By Distribution Channel
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Drug
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Allergan Type
        • 18.8.2.2.4. By Distribution Channel
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Drug
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Allergan Type
        • 18.8.3.2.4. By Distribution Channel
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Drug
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Allergan Type
        • 18.8.4.2.4. By Distribution Channel

19. Oceania Market 2015-2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Drug
    • 19.3.3. By Indication
    • 19.3.4. By Allergan Type
    • 19.3.5. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Drug
    • 19.4.3. By Indication
    • 19.4.4. By Allergan Type
    • 19.4.5. By Distribution Channel
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Drug
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By Allergan Type
        • 19.8.1.2.4. By Distribution Channel
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Drug
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By Allergan Type
        • 19.8.2.2.4. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2015-2022 and Forecast 2023-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
  • 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. South Africa
      • 20.3.1.3. Turkiye
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of MEA
    • 20.3.2. By Drug
    • 20.3.3. By Indication
    • 20.3.4. By Allergan Type
    • 20.3.5. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Drug
    • 20.4.3. By Indication
    • 20.4.4. By Allergan Type
    • 20.4.5. By Distribution Channel
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Drug
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By Allergan Type
        • 20.8.1.2.4. By Distribution Channel
    • 20.8.2. South Africa Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Drug
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By Allergan Type
        • 20.8.2.2.4. By Distribution Channel
    • 20.8.3. Turkiye Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Drug
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By Allergan Type
        • 20.8.3.2.4. By Distribution Channel
    • 20.8.4. North Africa Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Drug
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By Allergan Type
        • 20.8.4.2.4. By Distribution Channel

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Branding and Promotional Strategies, By Key Players
  • 22.3. Key Development Analysis
  • 22.4. Competition Deep Dive
    • 22.4.1. ALK Abello
      • 22.4.1.1. Overview
      • 22.4.1.2. Product Portfolio
      • 22.4.1.3. Key Financials
      • 22.4.1.4. Sales Footprint
      • 22.4.1.5. SWOT Analysis
      • 22.4.1.6. Strategy Overview
        • 22.4.1.6.1. Marketing Strategy
        • 22.4.1.6.2. Product Strategy
        • 22.4.1.6.3. Channel Strategy
    • 22.4.2. Stallergenes Greer
      • 22.4.2.1. Overview
      • 22.4.2.2. Product Portfolio
      • 22.4.2.3. Key Financials
      • 22.4.2.4. Sales Footprint
      • 22.4.2.5. SWOT Analysis
      • 22.4.2.6. Strategy Overview
        • 22.4.2.6.1. Marketing Strategy
        • 22.4.2.6.2. Product Strategy
        • 22.4.2.6.3. Channel Strategy
    • 22.4.3. Allergy Therapeutics
      • 22.4.3.1. Overview
      • 22.4.3.2. Product Portfolio
      • 22.4.3.3. Key Financials
      • 22.4.3.4. Sales Footprint
      • 22.4.3.5. SWOT Analysis
      • 22.4.3.6. Strategy Overview
        • 22.4.3.6.1. Marketing Strategy
        • 22.4.3.6.2. Product Strategy
        • 22.4.3.6.3. Channel Strategy
    • 22.4.4. Aimmune Therapeutics
      • 22.4.4.1. Overview
      • 22.4.4.2. Product Portfolio
      • 22.4.4.3. Key Financials
      • 22.4.4.4. Sales Footprint
      • 22.4.4.5. SWOT Analysis
      • 22.4.4.6. Strategy Overview
        • 22.4.4.6.1. Marketing Strategy
        • 22.4.4.6.2. Product Strategy
        • 22.4.4.6.3. Channel Strategy
    • 22.4.5. Biomay AG
      • 22.4.5.1. Overview
      • 22.4.5.2. Product Portfolio
      • 22.4.5.3. Key Financials
      • 22.4.5.4. Sales Footprint
      • 22.4.5.5. SWOT Analysis
      • 22.4.5.6. Strategy Overview
        • 22.4.5.6.1. Marketing Strategy
        • 22.4.5.6.2. Product Strategy
        • 22.4.5.6.3. Channel Strategy
    • 22.4.6. HAL Allergy group
      • 22.4.6.1. Overview
      • 22.4.6.2. Product Portfolio
      • 22.4.6.3. Key Financials
      • 22.4.6.4. Sales Footprint
      • 22.4.6.5. SWOT Analysis
      • 22.4.6.6. Strategy Overview
        • 22.4.6.6.1. Marketing Strategy
        • 22.4.6.6.2. Product Strategy
        • 22.4.6.6.3. Channel Strategy
    • 22.4.7. DBV Technologies
      • 22.4.7.1. Overview
      • 22.4.7.2. Product Portfolio
      • 22.4.7.3. Key Financials
      • 22.4.7.4. Sales Footprint
      • 22.4.7.5. SWOT Analysis
      • 22.4.7.6. Strategy Overview
        • 22.4.7.6.1. Marketing Strategy
        • 22.4.7.6.2. Product Strategy
        • 22.4.7.6.3. Channel Strategy
    • 22.4.8. Merck KGaA
      • 22.4.8.1. Overview
      • 22.4.8.2. Product Portfolio
      • 22.4.8.3. Key Financials
      • 22.4.8.4. Sales Footprint
      • 22.4.8.5. SWOT Analysis
      • 22.4.8.6. Strategy Overview
        • 22.4.8.6.1. Marketing Strategy
        • 22.4.8.6.2. Product Strategy
        • 22.4.8.6.3. Channel Strategy
    • 22.4.9. WOLWpharma
      • 22.4.9.1. Overview
      • 22.4.9.2. Product Portfolio
      • 22.4.9.3. Key Financials
      • 22.4.9.4. Sales Footprint
      • 22.4.9.5. SWOT Analysis
      • 22.4.9.6. Strategy Overview
        • 22.4.9.6.1. Marketing Strategy
        • 22.4.9.6.2. Product Strategy
        • 22.4.9.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology